Eupraxia Pharmaceuticals Inc. Announces Appointment of Bruce Cousins as President & CFO Medical Device Investing
Merck Hosts Organon Investor Day Outlining New Company's Vision, Focus and Business Model for Sustained Growth Pharmaceutical Investing
BLU Looming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Opdivo as Adjuvant Treatment for Patients with Muscle-Invasive Urothelial Carcinoma Biotech Investing
Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC Cannabis Investing News
ROSEN, A TOP RANKED LAW FIRM, Encourages BELLUS Health Inc. Investors with Losses over $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
BLU CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc. Biotech Investing
